首页> 外文期刊>The Annals of Thoracic Surgery: Official Journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association >Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer
【24h】

Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer

机译:正电子发射断层扫描在亚厘米级非小细胞肺癌中的临床意义

获取原文
           

摘要

Background This study evaluated the clinical significance of maximum standardized uptake value (SUVmax) on positron emission tomography (PET) in patients with subcentimeter non-small cell lung cancer (NSCLC).;Methods Between 2008 and 2014, 189 patients were investigated preoperatively by PET for c-N0 subcentimeter NSCLC, and SUVmax was reviewed. Pathologic invasiveness (PI) was defined as having at least one of the following factors: lymphatic invasion, vascular invasion, pleural invasion, or nodal metastasis. Survival rates were calculated by Kaplan-Meier estimation methods using the log-rank test.;Results Mean SUVmax was 1.7 ± 1.8 (range, 0.6 to 13.0), and the median was 1.0. PI was found in 28 (15%) patients with subcentimeter NSCLC. Multivariate analysis revealed that SUVmax was an independent significant clinical predictor of PI (p?= 0.0251) and a prognostic factor of overall survival (OS) (p?= 0.0485). A receiver operating characteristics curve elucidated the predictive cutoff value of PI as SUVmax?= 2.0. The high-SUVmax group (SUVmax >2.0; n?= 42) had significantly more radiologically pure-solid lesions (91% vs 14%; p < 0.0001) and postoperative nodal involvement (12% vs 0%; p?1 to ≤2 cm), and T1c (>2 to ≤3cm) [8, 9]. However, even c-N0 subcentimeter NSCLCs are not always in the early stage, and these tumors sometimes have nodal metastases and potential spread to locoregional or distant lesions after surgical resection [3, 5]. This finding indicates that “tumor size less than 1 cm” does not always indicate early-stage disease or absence of tumor spread. Additionally, the malignant behavior of these tumors is considered to be fully related to consolidation status on thin-section CT scans even for subcentimeter NSCLCs [3, 5].Fluorine 18 (18F)–fluorodeoxyglucose PET (FDG-PET) is widely used as an accurate noninvasive imaging test for identifying pulmonary malignant lesions. In general, the appropriate roles of FDG-PET in the evaluation of subcentimeter NCSLC remain unclear, mainly because of the high frequency of false-negative results caused by limitations in the resolution of the PET scanner, especially for small adenocarcinomas with a predominant lepidic component [10, 11, 12]. Conversely, we previously reported that FDG-PET was potentially effective to predict nodal involvement of subcentimeter NSCLC, which was strongly correlated with the consolidation status based on the findings of thin-section CT. Hence, FDG-PET could be a promising method as a quantitative assessment to predict the potential
机译:背景:本研究评估正电子发射断层显像(PET)在亚厘米级非小细胞肺癌(NSCLC)患者中的最大标准摄取值(SUVmax)的临床意义。方法:2008年至2014年,PET术前调查了189例患者。对于c-N0亚厘米NSCLC,以及SUVmax进行了综述。病理浸润性(PI)被定义为具有以下至少一种因素:淋巴管浸润,血管浸润,胸膜浸润或淋巴结转移。通过对数秩检验通过Kaplan-Meier估计方法计算存活率;结果平均SUVmax为1.7±1.8(范围0.6至13.0),中位数为1.0。在28厘米以下的NSCLC患者中发现了PI。多变量分析显示,SUVmax是PI的独立的重要临床预测指标(p?= 0.0251)和总体生存率(OS)的预后因素(p?= 0.0485)。接收机的工作特性曲线阐明了PI的预测截止值为SUVmax?= 2.0。高SUVmax组(SUVmax> 2.0; n = 42)显着高于放射学上的纯实性病变(91%vs 14%; p <0.0001)和术后淋巴结受累(12%vs 0%; p <0.0001)。 )低于低SUVmax组(SUVmax≤2.0; n?= 147)。 5年肺癌特异性OS(LCS-OS)阐明了研究的高SUVmax和低SUVmax组之间的显着差异(LCS-OS分别为92.3%和96.9%; p?= 0.0054),以及仅在薄层计算机体层摄影术中,纯固体亚厘米级NSCLC才发现癌症复发。在该研究的高SUVmax组中,尽管存在亚厘米级疾病,但肺叶切除术与叶下切除相比仍具有较好的3年无复发生存率(88.3%vs 50.0%; p?= 0.0453)。侵袭性,对亚厘米级NSCLC的预后有很大影响,特别是当肿瘤在薄层计算机断层扫描中显示为纯实体外观时;由于包括薄层计算机断层摄影(CT)在内的放射学手段的快速发展日常实践中已经发现了小型和早期肺癌[1] [1]。此外,发现亚厘米级非小细胞肺癌(NSCLC)的机会正在逐渐增加[2、3、4、5、6]。肿瘤大小是临床T描述符中最明显的预后因素之一[7] [7]。第八版肺癌的肿瘤,淋巴结转移(TNM)分类表明,根据肿瘤的大小,小型NSCLC的预后明显不同,这些专家建议进一步进行更改,以将T1细分为T1a(≤1cm), T1b(> 1到≤2cm)和T1c(> 2到≤3cm)[8,9]。然而,即使是c-N0厘米以下的非小细胞肺癌也不总是处于早期阶段,这些肿瘤有时具有淋巴结转移,并且可能在手术切除后扩散到局部或远处的病变[3,5]。该发现表明“小于1厘米的肿瘤大小”并不总是表明早期疾病或没有肿瘤扩散。此外,即使对于厘米以下的NSCLC,这些肿瘤的恶性行为也被认为与薄层CT扫描的巩固状态完全相关[3,5]。氟18(18F)-氟脱氧葡萄糖PET(FDG-PET)被广泛用作用于识别肺恶性病变的准确的无创成像测试。通常,FDG-PET在亚厘米级NCSLC评估中的适当作用尚不清楚,这主要是由于PET扫描仪分辨率的限制导致假阴性结果的发生频率很高,尤其是对于具有主要鳞状上皮成分的小腺癌[10、11、12]。相反,我们先前曾报道FDG-PET可能有效地预测了亚厘米级NSCLC的淋巴结转移,这与基于薄层CT的发现与巩固状态密切相关。因此,FDG-PET可能是一种有前途的方法,可以作为定量评估来预测潜在的

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号